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INVITED CONTRIBUTION FROM THE PRESIDENT
The Jerusalem Congress and its Scientific Program
The scientific program of the XIIth International Congress of
Nephrology to be held in Jerusalem on June 13—18, 1993 is now
complete! Acceptances have been received from almost all
invited speakers and the last series of adjustments has just been
set in place. A few places in the program have been left unfilled
deliberately in order to accommodate any clinical or research
developments of "late-breaking" origin. The new format is
unique and exciting; it differs totally from that of any previous
major meeting of which I am aware. Its design has been the
subject of frequent review and discussion by many people over
the past three years, both formally and informally. However, in
any last analysis, the major credit for the final product must go
to the ISN Advisory Program Committee (chaired by Dr. Barry
Brenner) and the Israeli Scientific Program Committee (co-
chaired by Drs. On Better and Jacques Bernheim with able
support from President J. B. Rosenfeld, Vice Presidents M. M.
Popovtzer and H. E. Eliahou, and Secretary General G. Bon-
er). I believe that you will be pleased when the new format and
its content are unveiled in Jerusalem for the first time.
The heart and core of the program is provided by the subject
matter of seven "themes" (Table I). Each "theme" is a
self-contained mini-meeting on a single topic whose program
will run continuously in parallel with that of other "themes" for
two to five days of the five-day Congress. Each theme will
accommodate up to five State-of-the-Art Lectures, nine Sym-
posia and multiple oral or poster Free Communication sessions.
The content of each theme will flow naturally and progressively
from relevant basic science to practical clinical nephrology. In
contrast to other meetings, the program will also feature a
number of presentations by invited speakers from other fields
whose science or clinical practice is relevant to nephrology.
Last, on any given day, the programs of the seven themes will
be surrounded by selections from sixteen additional Symposia
and seven State-of-the-Art Lectures on topics not covered in
one of the themes . . . plus frequent clinical case discussions, a
number of "debates" or panel discussions on timely clinical
topics, and a Nephrology Forum to be published subsequently
in Kidney International. The schematic outline of a reasonably
characteristic daily schedule is depicted in Figure 1.
The current status of State-of-the-Art Lectures in each of the
seven themes is displayed in Tables 2 and 3. Overall, the themes
will offer 30 such lectures by 13 speakers from the United
States, 11 from Europe, three from Canada, one from Israel,
and two who are yet to be announced. An additional six lectures
will be devoted to "The Kidney and the Calcium Regulating
System" (K. Kurokawa, Japan); "Biology, Physiology and
Pathophysiology of PTH-RP" (J. Martin, Australia); "Immu-
notactoid Nephropathy" (S. Korbet, USA); "Biology of Ag-
ing" (S. Gambert, USA); "FK506" (TBA); and "Mechanisms
of Tubulointerstitial Fibrosis" (E. Neilson, USA).
Tables 4 and 5 are illustrative of the great depth of coverage
that can be brought to an individual theme (in this case, Themes
2 and 6) via the presentation of eight or nine Symposia, each of
which includes three to four speakers. Collectively, the seven
themes will offer 51 such Symposia; an additional 16 Symposia
will be presented on subjects as diverse as "Natriuretic Sub-
stances," "Cyclosporine in Non-Transplant Renal Disease,"
"AIDS and the Kidney," "Hypertension in the Elderly,"
"Genetic Counseling in Inherited Kidney Diseases," "Polycys-
tic Kidney Disease," "Renal Phosphate Transport," etc.
A summary outline of the entire program (including a detailed
description of all Symposia) is included on page 521 of this issue
of the Journal. In my view, the overall program is a "tour de
force." In the whole, it will offer two Plenary lectures, 37
State-of-the-Art lectures, 67 Symposia, six Panel Discussions
on Clinical Nephrology, three "Debate" Panels on selected
clinical topics, three clinical case discussions, one Nephrology
Forum, and multiple Free Communication sessions (both oral
Table 1. The Major "Themes"
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No. of
No. Title Organizer(s) Days
Biology of Glomerular Injury H. L. Moses (USA) 5
R. C. Atkins (Australia)
2 Biology of the Tubule Epithelial Cell H. Murer (Switz.) 5
3 Regulation of the Immune Response I. Cohen (Israel) 5
T. Strom (USA)
4 Hypertension P. Corvol (France) 5
5 Acute Renal Failure K. Solez (Can.) 3
6 Dialysis R. Hakim (USA) 5
K. Koch (Ger.)
7 Diabetic Glomerulopathy G. C. Viberti (UK) 2
H. H. Parving (Den.)
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TIME
(Approx.)
THEME ADDITIONAL
TOPICS
1 2 3 4 5 6 7
0800 SOAL-l SOAL-1 SOAL-I SOAL-1 SOAL-I SOAL-l SOAL-I 1. SOAL
0845 SYMP-I SYMP-1 SYMP-1 SYMP-1 SYMP-l SYMP-l SYMP-1 I. SYMP
2. CASE
DISCUSSIOI'
1015 BREAK
1045 PLENARY LECTURE
1130 ORAL PRESENTATIONS/POSTER DISCUSSIONS
1230 LUNCH/POSTER DISCUSSIONS
1330 SYMP-2 SYMP-2 SYMP-2 SYMP-2 SYMP-2 SYMP-2 SYMP-2 I. SYMP
2. "DEBATE"
PANEL-i
3. "DEBATE"
PANEL-2
1500 BREAK
1530 ORAL PRESENTATIONS/POSTER DISCUSSIONS
Fig. 1. Schedule for day I (Monday, June 14, 1993). Abbreviations are: SOAL, State-of-the-art Lecture; SYMP, symposium.
Table 2. State-of-the-Art Lectures
Theme I. Biology of Glomerular Injury
Integrins E. I. Rouslahti ((USA)
Cytokines/Growth Factors H. L. Moses (USA)
Endothelial-Leukocyte Interactions R. Cotran (USA)
Vasoactive and Proinflammatory Mediators of Glomerular Injury G. Remuzzi (Italy)
Pathogenesis and Clinical Spectrum of Focal Glomerular Sclerosis H. G. Rennke (USA)
Theme 2. Biology of the Tubule Epithelial Cell
Kidney Cells in Culture: A Way to Understand Tubule Function at a Molecular Level H. Murer (Switz.)
Na-T-ATPase: Structure, Function and Gene Regulation J. Lingrel (USA)
Structure and Function of Water Channels W. Harris (USA)
Structure-Function Studies of the Cystic Fibrosis Gene Product R. A. Frizzel (USA)
Molecular Biology of Na/H-Exchanger Isoforms J. Pouyssegur (France)
Theme 3. Regulation of the Immune Response
T-Cell Receptors TBA*
Models of Autoimmunity I. Cohen (Israel)
T-Cells in Autoimmunity and Allograft Rejection A. Krensky (USA)
Immunologic Tolerance T. Strom (USA)
* To Be Announced
Table 3. State-of-the-Art Lectures
Theme 4. Hypertension
Angiotensin Generation and Metabolism M. Schalekamp (Neth.)
Genetics of Human Hypertension R. Williams (USA)
Ecto-Enzymes and Blood Pressure Regulation P. Corvol (France)
Intracellular Signaling Mechanisms in Hypertension P. Hamet (Can.)
Ambulatory Monitoring of Blood Pressure G. Mancia (Italy)
Theme 5. Acute Renal Failure
Metabolic Basis of Cellular Injury L. Mandel (USA)
Role of Calcium in Cell Injury E. Carafoli (Switz.)
Renal Biopsy in Acute Renal Failure K. Solez (Can.)
Theme 6. Dialysis
Adequacy of Dialysis R. Lindsay (Can.)
Erythropoietin: The Promise and the Facts J. Eschbach (USA)
Biocompatibility of Dialysis Membranes E. Ritz (Ger.)
Dialysis of the Diabetic Patient A. Collins (USA)
Immunological Considerations in the Dialysis Patient L. Chatenoud (France)
Theme 7. Diabetic Glomerulopathy
Pathogenesis of Diabetes Mellitus H. Keen (UK)
Animal and Human Models of Renal Injury in Diabetes M. Mauer (USA)
Robinson: The Jerusalem Congress 249
Table 4. Symposia in Theme 2 (Biology of Tubule Epithelial Cell)
Table 5. Symposia in Theme 6 (Dialysis)
and poster). Its sheer size provides the largest-ever assemblage
of information on nephrology and an unequalled opportunity to
explore a major nephro!ogica! "theme" in great depth at a
single meeting. Alternatively, one will be able to design a
program according to one's own interests and choice by se-
quential attendance at lectures, symposia, etc., from different
themes or surrounding offerings.
An outstanding scientific program and a parallel opportunity
for "networking" with colleagues from around the world pro-
vide ample justification for visiting one of the world's special
cities. From the Opening Ceremony at the Sultan's Pool below
the ancient walls of the Old City to a folklore performance at the
Closing Ceremony, the Congress promises to follow in the great
tradition of past Congresses in other settings. It is my hope that
the availability of low cost accommodations, airfare, and the
lowest registration fee in recent Congress history will make it
possible for each of you to join with me in Jerusalem in June,
1993.
The ISN will also provide a number of grants for the partial
support of the travel expenses of nephrologists under the age of
35. Complete information on their availability can be obtained
by writing directly to Prof. Claude Arnie!, INSERM U. 251,
Faculté de Médecine Xavier Bichat, 16 rue Henri Huchard,
75018 Paris, France (FAX: 33-1-42-28-15-64). For further infor-
mation about the Congress itself, write to the Secretariat, XIIth
International Congress of Nephro!ogy, P. 0. Box 50006, Tel
Aviv 61500, Israel (Tel.: 972-3-5174571; FAX: 972-3-660325).
The deadline for receipt of abstracts is December 15, 1992.
RoscoE R. ROBINSON, MD
President
Tubule Cells in Culture. Chair: M. Cereijido (Mex.); Other Participants: U. Hopfer (USA), P. Ronco (France), J. J. Grantham (USA)
Tubule Cells in Culture: Models of Polarity. Chair: W. .1. Nelson (USA); Other Participants: D. Louvard (France), E. Rodriquez-Boulan
(USA), D. Brown (USA).
Na-K-ATPase. Chair: D. Fambrough (USA); Other Participants: A. Doucet (France), B. Rossier (Switz.), H. Wald (Israel).
H-ATPase. Chair: S. Gluck (USA); Other Participants: M. Caplan (USA), M. Bichara (France), E. Bello-Reuss (USA).
Sodium/Potassium Channels. Chair: G. Giebisch (USA); Other Participatns: R. Greger (Ger.), W. Guggino (USA), M. Lazdunski (France).
Chloride Channels. Chair: Q. Al-Awqati (USA); Other Participants: Z. I. Cabantchick (Israel), T. Jentsch (Ger.), J. W. Hanrahan (Can.).
Na-Dependent Co-Transport. Chair: J. Handler (USA); Other Participants: E. Hoffman (Den.), J. Biber (Switz.), G. Friedlander (France).
Anion-Exchangers. Chair: S. L. Alper (USA); Other Participants: P. 5, Aronson (USA), R. R. Kopito (USA), R. G. Knickelbein (USA).
Advances in Hemodialytic Techniques. Chair: N. W. Levin (USA); Other Participants: K. M. L. Leunissen (Neth.), H. Graf (Austria),
H. G. Sieberth (Ocr.).
Advances in Peritoneal Dialysis Technology. Chair: J. Diaz-Buxo (USA); Other Participants: B. Lindholm (Sweden), M. Nakamota (Jap.),
F. Gotch (USA).
Erythropoietin I. Chair: F. Valderrabano (Spain); Other Participants: A. Nissenson (USA), U. Gafter (Israel), C-S. Lee (Korea).
Erythropoietin II. Chair: V. Lim (USA); Other Participants: C. G. Winnearls (UK), R. Castillo (Spain).
Clinical Relevance of Biocompatibility. Chair: C. Van Yperse!e (BeIg.); Other Participants: R. Van Holder (BeIg.), J. Bergstrom (Sweden),
L. Henderson (USA).
Peritoneal Dialysis. Chair: N. Thompson (Australia); Other Participants: F. B. Pederson (Den.), R. Gagnon (Can.), R. McTier (UK).
Improvements in Delivery of Dialysis. Chair: V. Bonomini (Italy); Other Participants: J. Botella (Spain), G. Lonneman (Ger.), T. Depner (USA).
Diagnosis and Treatment of Bone Diseases and Metastatic Calcification. Chair: F. Llach (USA); Other Participants: 0. Coen (Italy),
D. J. Sherrard (USA), T. DrUeke (France).
Dialysis, Pheresis and Immunoabsorption in Special Populations. Chair: C. M. Lockwood (UK); Other Participants: T. K. S. Rao (USA),
C. Olbricht (Ger.).
